rs370412052
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM1BP4_Moderate
The NM_000256.3(MYBPC3):c.1286C>T(p.Ala429Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000869 in 1,611,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.1286C>T | p.Ala429Val | missense_variant | Exon 15 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.1286C>T | p.Ala429Val | missense_variant | Exon 14 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.1286C>T | non_coding_transcript_exon_variant | Exon 15 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 34AN: 244698Hom.: 0 AF XY: 0.000143 AC XY: 19AN XY: 132938
GnomAD4 exome AF: 0.0000610 AC: 89AN: 1459500Hom.: 0 Cov.: 31 AF XY: 0.0000496 AC XY: 36AN XY: 725870
GnomAD4 genome AF: 0.000335 AC: 51AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000389 AC XY: 29AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Variant classified as Uncertain Significance - Favor Benign. The p.Ala429Val var iant in MYBPC3 has been identified in at least 4 individuals with HCM (Gruner 20 11, Waldmuller 2011, LMM data). This variant has also been identified in 0.2% (1 5/8188) of African American chromosomes by the Exome Aggregation Consortium (ExA C, http://exac.broadinstitute.org; dbSNP rs370412052). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, while the clinical significance of the p.Ala4 29Val variant is uncertain, its frequency suggests that it is more likely to be benign. -
Variant summary: MYBPC3 c.1286C>T (p.Ala429Val) results in a non-conservative amino acid change located in the Immunoglobulin-like domain of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 244698 control chromosomes, predominantly at a frequency of 0.0015 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 1.5 fold of the estimated maximal expected allele frequency for a pathogenic variant in MYBPC3 causing Hypertrophic Cardiomyopathy phenotype (0.001), suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.1286C>T has been reported in the literature in individuals affected with Hypertrophic Cardiomyopathy (Waldmuller_2011, Gruner_2011, Bick_2012, Leong_2017). These reports do not provide unequivocal conclusions about association of the variant with Hypertrophic Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (VUS n=3, likely benign n=3). Based on the evidence outlined above, the variant was classified as likely benign. -
Cardiomyopathy Benign:2
- -
- -
Hypertrophic cardiomyopathy Benign:2
- -
- -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25637381, 21750094, 24055113, 22958901, 23299917, 34621001, 21511876, 37652022) -
Primary familial hypertrophic cardiomyopathy Uncertain:1
- -
Hypertrophic cardiomyopathy 4 Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at